Drug–drug interactions of new active substances: mibefradil example.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 273, doi. 10.1007/s002280000150
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2000 AND VI 56 AND IP 3
Results: 14
1
2
Intravesical administration of 5-aminolevulinic acid (5-ALA) : Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 241, doi. 10.1007/s002280000151
- By:
- Publication type:
- Article
3
Effect of fluconazole on plasma fluvastatin and pravastatin concentrations.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 225, doi. 10.1007/s002280000127
- By:
- Publication type:
- Article
4
A randomized controlled assessment of the systemic activity of budesonide when given once or twice daily via Turbuhaler.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 207, doi. 10.1007/s002280000134
- By:
- Publication type:
- Article
5
ANNOUNCEMENTS.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 275, doi. 10.1007/s002280000172
- Publication type:
- Article
6
Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 219, doi. 10.1007/s002280000133
- By:
- Publication type:
- Article
7
Psychomotor effects of zaleplon and thioridazine coadministration.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 211, doi. 10.1007/s002280000129
- By:
- Publication type:
- Article
8
Deviations from evidence-based prescribing of non-steroidal anti-inflammatory drugs in three European regions.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 269, doi. 10.1007/s002280000144
- By:
- Publication type:
- Article
9
Hydroquinine pharmacokinetics after oral administration in adult patients with muscle cramps.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 263, doi. 10.1007/s002280000128
- By:
- Publication type:
- Article
10
Pharmacokinetics and organ distribution of intravenous and oral methylene blue.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 247, doi. 10.1007/s002280000124
- By:
- Publication type:
- Article
11
Oral vasoactive medication in intermittent claudication: utile or futile?
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 199, doi. 10.1007/s002280000114
- By:
- Publication type:
- Article
12
Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 259, doi. 10.1007/s002280000125
- By:
- Publication type:
- Article
13
High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfotiamine.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 251, doi. 10.1007/s002280000131
- By:
- Publication type:
- Article
14
Genotype and phenotype of cytochrome P<sub>450</sub> 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 3, p. 231, doi. 10.1007/s002280000116
- By:
- Publication type:
- Article